AXQ Capital’s Bristol-Myers Squibb BMY Stock Holding History

AXQ Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.83M	Buy	+30,117	New	+$1.76M	0.24%	124
2025 Q4	–	Sell	-38,456	Closed	-$1.73M	–	741
2025 Q3	$1.73M	Buy	38,456 +949	+3%	+$44.3K	0.66%	7
2025 Q2	$1.74M	Buy	37,507 +28,051	+297%	+$1.38M	0.56%	23
2025 Q1	$577K	Buy	+9,456	New	+$551K	0.23%	153
2024 Q3	–	Sell	-51,983	Closed	-$2.16M	–	441
2024 Q2	$2.16M	Buy	+51,983	New	+$2.33M	0.5%	39
2024 Q1	–	Sell	-5,700	Closed	-$292K	–	637
2023 Q4	$292K	Buy	+5,700	New	+$299K	0.08%	388
2023 Q3	–	Sell	-4,100	Closed	-$262K	–	473
2023 Q2	$262K	Sell	4,100 -25,190	-86%	-$1.69M	0.32%	141
2023 Q1	$2.03M	Buy	29,290 +11,098	+61%	+$783K	0.81%	3
2022 Q4	$1.31M	Buy	+18,192	New	+$1.37M	0.91%	10

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AXQ Capital's BMY Position: Q1 2026 in Review

AXQ Capital opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 30,117 shares worth $1.83M. The stake represents 0.24% of the portfolio and ranks #124 among its holdings. This is a return to the name: AXQ Capital previously reported a position in BMY as recently as Q3 2025.

AXQ Capital first reported a position in BMY in Q4 2022 and has held it in 9 quarters since. The position peaked at $2.16M in Q2 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

AXQ Capital held 30,117 shares of Bristol-Myers Squibb worth $1.83M as of Q1 2026.
Bristol-Myers Squibb was a new AXQ Capital position in Q1 2026.
Bristol-Myers Squibb made up 0.24% of AXQ Capital's portfolio in Q1 2026, its #124 holding.
AXQ Capital first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 9 quarters since.
AXQ Capital's Bristol-Myers Squibb position peaked at $2.16M in Q2 2024.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.